Blackstone’s Regeneron Pharmaceuticals REGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.57M Buy
+2,516
New +$1.71M ﹤0.01% 203

Other funds holding REGN

Blackstone's REGN Position: Q2 2026 in Review

Blackstone opened a new position in Regeneron Pharmaceuticals (REGN) in Q2 2026: 2,516 shares worth $1.57M. The stake represents ﹤0.01% of the portfolio and ranks #203 among its holdings.

1,346 funds tracked by Wall St. Rank hold REGN as of Q2 2026.

  • Blackstone held 2,516 shares of Regeneron Pharmaceuticals worth $1.57M as of Q2 2026.
  • Regeneron Pharmaceuticals was a new Blackstone position in Q2 2026.
  • Regeneron Pharmaceuticals made up ﹤0.01% of Blackstone's portfolio in Q2 2026, its #203 holding.
  • 1,346 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.

Based on Blackstone's 13F filing for Q2 2026, filed 14 Aug 2026.